Abstract | BACKGROUND: OBJECTIVE: METHODS: The study included 32 patients with AD who were suffering PA. Patients were randomized into two groups. In total, 16 patients used 0.03% tacrolimus ointment and 16 patients used vaseline as placebo. All groups applied topical treatments to their perianal area twice daily for 4 weeks. The treatments were then reversed for 4 weeks after a 2 weeks wash out period. RESULTS: In total, 32 patients with AD who had refractory anal itching were enrolled in this study. None of the patients had obtained successful results with previous treatments. There was a statistically significant decrease in the recorded EASI, DLQI and itching scores for the tacrolimus group compared to the placebo group at weeks 4 and 6 of treatment (p < 0.05). CONCLUSION: Topical tacrolimus treatment was well tolerated and effective in controlling persistent PA in AD patients.
|
Authors | Haydar Ucak, Betul Demir, Demet Cicek, Selma Bakar Dertlioglu, Zeynep Meltem Akkurt, Derya Ucmak, Nurhan Halisdemir |
Journal | The Journal of dermatological treatment
(J Dermatolog Treat)
Vol. 24
Issue 6
Pg. 454-7
(Dec 2013)
ISSN: 1471-1753 [Electronic] England |
PMID | 23638997
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Antipruritics
- Emollients
- Immunosuppressive Agents
- Petrolatum
- Tacrolimus
|
Topics |
- Administration, Topical
- Adolescent
- Adult
- Antipruritics
(administration & dosage)
- Dermatitis, Atopic
(complications)
- Emollients
(administration & dosage)
- Female
- Humans
- Immunosuppressive Agents
(administration & dosage)
- Male
- Middle Aged
- Petrolatum
(administration & dosage)
- Pruritus Ani
(drug therapy)
- Tacrolimus
(administration & dosage)
- Young Adult
|